- [GENE THERAPY AND REGULATION OF GENE EXPRESSION]
- [NON-CODING RNA IN HEPATOCARCINOMA AND OTHER LIVER DISEASES]
LncRNAs in the Type I Interferon Antiviral Response
Beatriz Suarez, Laura Prats-Mari, Juan P Unfried, Puri Fortes
The proper functioning of the immune system requires a robust control over a delicate equilibrium between an ineffective response and immune overactivation. Poor responses to viral insults may lead to chronic or overwhelming infection, whereas unrestrained activation can cause autoimmune diseases and cancer. Control over the magnitude and duration of the antiviral immune response is exerted by a finely tuned positive or negative regulation at the DNA, RNA, and protein level of members of the type I interferon (IFN) signaling pathways and on the expression and activity of antiviral and proinflammatory factors.
As summarized in this review, committed research during the last decade has shown that several of these processes are exquisitely regulated by long non-coding RNAs (lncRNAs), transcripts with poor coding capacity, but highly versatile functions. After infection, viruses, and the antiviral response they trigger, deregulate the expression of a subset of specific lncRNAs that function to promote or repress viral replication by inactivating or potentiating the antiviral response, respectively.
These IFN-related lncRNAs are also highly tissue- and cell-type-specific, rendering them as promising biomarkers or therapeutic candidates to modulate specific stages of the antiviral immune response with fewer adverse effects.
CITATION Int J Mol Sci. 2020 Sep 3;21(17):6447. doi: 10.3390/ijms21176447.